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Abstract Reactive oxygen species (ROS) can damage
proteins, cause lipid peroxidation, and react with DNA,
ultimatelyresultinginharmfuleffects.Antioxidantsconstitute
one of the defense systems used to neutralize pro-oxidants.
Since pro-oxidants and antioxidants are found ubiquitously in
nature, pro-and antioxidant effects of individual compounds
and of mixtures receive much attention in scientific research.
A major bottleneck in these studies, however, is the
identification of the individual pro-oxidants and antioxidants
in mixtures. Here, we describe the development and valida-
tion of an on-line post-column biochemical detection system
for ROS-producing compounds and antioxidants in mixtures.
Inclusion of cytochrome P450s and cytochrome P450
reductase also permitted the screening of compounds that
need bioactivation to exert their ROS-producing properties.
This pro-oxidant and antioxidant detection system was
integrated on-line with gradient HPLC. The resulting high-
resolution screening technology was ableto separate mixtures
of ROS-producing compounds and antioxidants, allowing
each species to be characterized rapidly and sensitively.
Keywords Pro-oxidant.Antioxidant.ROS.
Bioactivation.On-line.Biochemicaldetection
Introduction
The potentially toxic and beneficial properties of pro-
oxidants and antioxidants have made them the focus of
many studies. Pro-oxidants may represent a threat to health,
whereas antioxidants may counteract these effects by
scavenging pro-oxidants [1, 2]. Antioxidants are very
important in industrial processes as well as in biological
systems. They are known to possess anti-inflammatory [3],
anti-cardiovascular disease [4], antineurogenerative [5], and
anticancer properties [6]. Imbalances between pro-oxidants
and antioxidants in favor of the pro-oxidants may result in
oxidative stress, which in turn may result in oxidative
damage [7] of cellular components in the form of lipid
peroxidation, protein denaturation or DNA conjugation [8].
Oxidative stress has been associated with many diseases
like cancer [6], post-ischemic and neural degradation [2],
Parkinson’s and Alzheimer disease [5], AIDS [9], and aging
and cardiovascular diseases [4]. The metabolism of pro-
oxidants by cytochrome P450s is another important process
that can result in the formation of reactive oxygen species
(ROS) [10, 11].
Because antioxidants may neutralize the potentially
harmfuleffectsof directpro-oxidantsorpro-oxidantsformed
upon bioactivation, much of the work done in this field has
been directed at synthesizing antioxidants, in some cases
organ- or tissue-specific ones [12–14]. In addition, the food
industry pays a great deal of attention to antioxidants in
foods. Phenols in tea [15], fish oils [16], curcumin in curry
[17] and flavanoids in plants [18] are only a few examples
of the large number of natural compounds that have been
and are being studied for their positive, antioxidant-based,
effects. When the pro-oxidant or antioxidant effects of
natural extracts or synthetic compounds are investigated,
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assays that measure the pro-oxidant or antioxidant effects of
compounds are also described [22–24]. However, when
individual compounds in mixtures need be analyzed for
their pro-oxidant or antioxidant properties using these
techniques, cumbersome gradient HPLC separations are
required before the purified compounds can be character-
ized. Moreover, care must be taken to ensure that the
purified compounds are not oxidized or degraded in air
before analysis. One strategy that could be employed to
circumvent the need for this cumbersome purification and
subsequent screening process is high-resolution screening
(HRS), which stands for “on-line post-column biodetection
after HPLC separation.” HRS methodologies, which screen
individual compounds in mixtures for affinity, have been
developed for receptors (e.g., the estrogen receptor [25]),
enzymes (e.g., cathepsin B [26], cytochrome P450s [27]),
and antibodies (e.g., digoxin antibodies [28]). These HRS
strategies have proven to be very useful for the rapid
profiling and identifying of individual ligands in active
mixtures, especially when HRS systems are run simulta-
neously with MS [29]. Moreover, the use of these fast HRS
strategies can result in a reduced risk of the oxidation or
degradation of sample components before analysis.
This paper presents the development and validation of a
HRS-based on-line post-column detection system for the
detection of ROS-producing compounds as well as antiox-
idants in mixtures. This so-called pro-oxidant and antioxidant
detection (PAD) system is based on the oxidation of 4-
hydroxyphenylacetic acid (4HPAA) by H2O2 in the presence
of horseradish peroxidase (HRP) to a highly fluorescent
dimer [30, 31]. Scheme 1 shows the general principles of the
assay. H2O2 may be present as such or it may be formed
from superoxide anion radicals (resulting from ROS-produc-
ing compounds) in the presence of superoxide dismutase
(SOD). After optimization, the on-line detection system was
validated with the well-known ROS-producing compounds
paraquat, menadione and duroquinone, and the antioxidants
L-ascorbic acid and glutathione, in flow injection analysis
(FIA) mode. Finally, the on-line PAD system was coupled to
gradient HPLC and thus used in HRS mode to screen
individual compounds in mixtures for their ROS-producing
and/or antioxidant properties.
Experimental section
Materials
L-ascorbic acid, L-glutathione (reduced; GSH) and 4-
hydroxyphenylacetic acid (4-HPAA) were purchased from
Aldrich (Zwijndrecht, The Netherlands). Tween 20, mena-
dione, polyethyleneglycol 6000 (PEG6000), polyethylene-
glycol 3350 (PEG3350), methylviologen (paraquat
dichloride), peroxidase (horseradish, type I; HRP), and
superoxide dismutase (from bovine erythrocytes; SOD)
were purchased from Sigma (Zwijndrecht, The Nether-
lands). β-Nicotinamide adenine dinucleotide phosphate
tetra sodium salt (NADPH) was from Applichem (Lokeren,
Belgium). Methanol (MeOH) and isopropanol (IPA) were
purchased from Riedel de Haën (Seelze, Germany).
Acetonitrile (ACN) was from Baker (Deventer, The
Netherlands). The MeOH, ACN and IPA were of HPLC
reagent grade. Rat liver microsomes (β-NF induced) were
prepared as described elsewhere [32]. In short: livers from
β-NF induced rats were homogenized at 4 °C in two
volumes of 50 mM potassium phosphate buffer (pH 7.4)
with 0.9% sodium chloride using a Potter-Elvehjem
(Sigma) homogenizer. The homogenate was centrifuged
for 20 min at 12.000×g, and the supernatant obtained was
further centrifuged for 60 min at 100.000×g. The resulting
pellet was washed twice and subsequently resuspended in
50 mM potassium phosphate buffer (pH 7.4), 0.9% sodium
chloride, and 25% glycerol, and stored at −80 °C. The
protein concentration in the microsomes was determined as
13.1 mg/ml. Protein concentrations were determined with
the standard Bio-Rad (Hercules, CA, USA) protein assay
based on the method of Bradford.
Instrumentation
A Gilson 234 auto injector (Villiers-le-Bel, France) equipped
with a Rheodyne (Bensheim, Germany) six-port injection
valve (injection loop, 50 μl) was used for sample injections.
A Knauer K-500 HPLC pump (Berlin, Germany) was used
to deliver the injected samples into the on-line PAD system
in FIA mode. Two Knauer K-500 HPLC pumps were used to
deliver the cofactors, substrate and enzymes by means of
superloops (SL-A and SL-B) (50 ml, Pharmacia, Peapack,
NJ, USA), which were kept on ice, into the PAD system.
Scheme 1 Schematic representation of the principles of the biochem-
ical assay
872 Anal Bioanal Chem (2007) 388:871–879Prior to detection via an Agilent 1100 (Waldbronn,
Germany) series fluorescence detector (λex 320 nm; λem
409 nm), a knitted reaction coil (0.25 mm i.d.; 1.59 mm o.d.;
internal volume of 75 μl) positioned in a Shimadzu CTO-
10AC column oven (Duisburg, Germany), was used to
perform the enzymatic reaction on-line. To reduce pump
pulsing, flow restrictors were inserted between the pumps
and the superloops. The flow restrictors were made in a
similar way to the ones used by Kool et al. [27].
Pro-oxidant and antioxidant assay optimization
The initial optimization of the biochemical assay for the PAD
system was performed off-line on a Shimadzu RF-1501
spectrofluorometer (λex 320 nm; λem 409 nm), before the
biochemical assay was transferred to the on-line format for
further optimization. All measurements were performed in
triplicate at 37 °C in quartz cuvettes with total volumes of
2 ml. Different concentrations of enzymes (rat liver
microsomal cytochrome P450s and cytochrome P450
reductase, SOD and HRP), cofactor NADPH, and 4-HPAA
were tested. Blocking reagents and detergents (that can
improve the resolution of the PAD system) [27] and organic
modifiers (that are necessary when the PAD system is
operated in on-line gradient HPLC mode) were investigated
as well. Potassium phosphate buffer (50 mM; pH 7.8) was
used in all experiments. Initial conditions were rat liver
microsomes (50 μg/ml), NADPH (40 μM), 4-HPAA
(1 mM), SOD (10 U/ml), and HRP (10 U/ml). Reactions
were started after 5 min of pre-incubation with the
addition of paraquat (70 μM). The different parameters
were optimized in the abovementioned order. When the
optimal (or best compromise) concentration of every
parameter was subsequently used in the optimization of
the next parameter. After the optimization process, the
optimized conditions were used in the PAD system in
FIA and HPLC mode.
Pro-oxidant and antioxidant detection system in flow-
injection analysis mode
A schematic view of a similar on-line detection system to
the PAD system used in FIA mode is shown and described
elsewhere [27]. The main difference between the PAD
system used in FIA mode and that used in HPLC mode is
the replacement of a carrier solution used in FIA mode with
a gradient reversed-phase HPLC system. The general
scheme for a PAD system coupled on-line to gradient
reversed-phase HPLC (described in the next paragraph) is
shown in Fig. 1, which also shows the schematics of the
PAD system in general. The continuous mixing of enzymes
(cytochrome P450s and cytochrome P450 reductase, HRP
and SOD) from SL-A and cofactors/substrate (NADPH/4-
HPAA) from SL-B with a carrier solution in a reaction coil
is the basic principle of the PAD system (when used in FIA
mode). After mixing in a knitted reaction coil, ROS formed
from pro-oxidants (after cytochrome P450/cytochrome
P450 reductase-mediated bioactivation) are converted by
SOD to (relatively stable) H2O2. The subsequent H2O2-
dependent conversion of non-fluorescent 4-HPAA to its
fluorescent dimer by HRP yields a spectroscopic handle for
the efficient measurement of ROS formation. Thus, the
ROS formed by eluting compounds give rise to a temporary
increase in the formation of fluorescent product, which is
Fig. 1 Schematic view of the PAD system used in HPLC mode.
Superloop A (SL-A) and superloop B (SL-B) are used to deliver
enzymes and substrates to the reaction coil, respectively. ROS-
producing pro-oxidants and antioxidants are introduced into the system
by a gradient reversed-phase HPLC system. Antioxidants and ROS-
producing compounds temporarily alter the amount of fluorescent
product formed, and this change is detected with a fluorescence (FLD)
detector. After HPLC, the make-up pumps produce a counteracting
gradient, resulting in a PAD-compatible constant organic modifier
concentration. The effluent is then split 1:9 (90% to UV detection and
10% to CYP EAD). AS, autosampler
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contains a ROS-producing compound, continuous oxidation
of the 4-HPAA results in an elevated fluorescent baseline.
In this situation, injection of antioxidants causes a tempo-
rary decrease in 4-HPAA oxidation, resulting in a negative
peak in the PAD system. Thus, the system is sensitive to
both ROS-producing compounds and antioxidants.
Liquid chromatography coupled to the pro-oxidant
and antioxidant detection system
A general scheme for the PAD system coupled on-line to
gradient reversed-phase HPLC is shown in Fig. 1. Gradient
HPLC separations were performed using a 30 mm length ×
2 mm i.d. stainless steel column (Luna 3 μ C18(2),
Phenomenex, Torrance, CA, USA). When the PAD system
was operated in HPLC mode, two pumps were used to
control the LC gradient and two pumps were used directly
after the HPLC column to compensate for the increased
concentration of organic modifier (during the gradient)
before the delivery of the effluent to the PAD system. The
following gradient was used for the HPLC separations: an
initial flow rate of 300 μl/min for 3 min at H2O:MeOH
(95:5); a decreasie in the flow rate gradient for 6 min to
150 μl/min H2O:MeOH (5:95); 14 min with H2O:MeOH
(5:95) at a flow rate of 150 μl/min. Thereafter, the column
was re-equilibrated to the starting conditions in 5 min. To
maintain a constant concentration of MeOH after the HPLC
column, a second gradient with an increasing flow-rate was
included in the system, after HPLC separation, with an
initial flow-rate of 700 μl/min H2O:MeOH (4:1) for
4.5 min. An increase in the flow-rate gradient for 6 min
to 850 μl/min H2O:MeOH (100:0) was then followed by a
post-gradient flow-rate of 850 μl/min H2O:MeOH (100:0)
for 14 min. Finally, re-equilibration to starting conditions
was performed in 5 min. The H2O and MeOH of the
increasing flow-rate gradient contained 100 mg/L Tween
20. The final constant flow-rate was 1000 μl/min, with a
MeOH concentration of 15% in H2O. This flow was
connected to a T-piece and split 1/9 with a flow splitter.
90% was directed to the UV detector, while10% was
pumped into the PAD system. For HPLC analysis, all tested
compounds were dissolved in 30% MeOH in water.
Results and discussion
The primary aim of this study was to develop and validate a
HRS-based on-line post-column detection system for the
detection of ROS-producing compounds and antioxidants
in mixtures. The biochemical assay is based on the
oxidation of 4-hydroxyphenylacetic acid (4HPAA) to a
highly fluorescent dimer (see Scheme 1). After optimiza-
tion, the on-line detection system was validated using the
well-known ROS-producing compounds paraquat, menadi-
one, and duroquinone, as well as the antioxidants L-ascorbic
acid and glutathione, in flow injection analysis (FIA) mode.
The on-line PAD system was then coupled to gradient
HPLC and this was used in HRS mode to screen for
individual compounds in mixtures based on their ROS-
producing and/or antioxidant properties.
Optimization of pro-oxidant and antioxidant detection assay
TheoptimizationofthebiochemicalassayforthePADsystem
was conducted first in an off-line batch format before the
optimized biochemical assay was transferred to the PAD
system in FIA and HPLC modes. Paraquat was used as a
model ROS-producing compound. The following parameters
wereoptimized:enzymeconcentrations(ratlivermicrosomes,
SOD, and HRP), cofactor NADPH and substrate 4-HPAA,
blocking reagents PEG3350 and PEG6000, the detergent
Tween 20 (which can improve the resolution of the on-line
PAD system) and organic modifiers (that are necessary when
the on-line PAD system is operated on-line in gradient HPLC
mode). All optimizations were performed without the pres-
enceofparaquatasthecontinuousROS-producingcompound
inSL-B.However,paraquat(0.036mM)wasaddedtotheSL-
B in the final optimized system in order to permit measure-
ments of both pro-oxidants and antioxidants using the on-line
PAD system.
First, the concentration of cytochrome P450s/cytochrome
P450 reductase-containing rat liver microsomes was evalu-
ated. Insertion of this important, mainly hepatic, biotrans-
formation system permits the reductive bioactivation of
compounds that need to be bioactivated before they can
exhibittheirROS-producingeffects(e.g.,paraquat[33]). For
the liver microsomes, it was found that higher concen-
trations resulted in an increase in fluorescence signals up to
at least 150 μg/ml (microsomal protein concentration). This
is due to increased cytochrome P450s/cytochrome P450
reductase-mediated redox cycling [33]. Since the use of
high concentrations of rat liver microsomes increases the
risk that on-line biochemical detection systems will become
clogged [27], a concentration of 50 μg/ml rat liver micro-
somes was used in subsequent experiments. For SOD,
concentrations higher than 14 U/ml did not increase the
fluorescence signal significantly. Therefore, this SOD
concentration was used in subsequent experiments. For
HRP, the same effect was observed at a concentration of
18 U/ml, and so this concentration was employed from then
on. Increasing the concentration of 4-HPAA led to the
increased formation of fluorescent dimer, up to a concen-
tration of 1.2 mM, after which the additional increase in
sensitivity was counteracted by an increase in noise. A 4-
HPAA concentration of 1.2 mM was therefore used in later
874 Anal Bioanal Chem (2007) 388:871–879experiments. An NADPH concentration of greater than
44 μM did not increase the assay performance significantly
and so this concentration was adopted. For the polymers
PEG3350 and PEG6000, concentrations of up to 5 mg/ml
did not produce significant differences in assay performance.
Since a PEG6000 concentration of 1 mg/ml is sufficient to
reduce possible peak broadening in on-line biodetection
systems [27], this concentration was in subsequent experi-
ments. Detergents, such as Tween 20, can be used to prevent
(membrane-bound) enzymes from adhering to reaction coils
in on-line biodetection systems, thereby resulting in reduced
peak broadening [27]. Solubilization of membrane-bound
enzymes, such as cytochrome P450s, can occur at high
detergent concentrations and will inactivate the microsomes
under the present conditions. A Tween 20 concentration of
100–200 mg/l showed minimal (5–20%) enzyme denatur-
ation. These Tween 20 concentrations are known to
efficiently reduce peak broadening when used in cyto-
chrome-P450-containing on-line biodetection systems [27].
A Tween 20 concentration of 100 mg/l was therefore used
from then on. Organic modifiers may be useful for
preventing enzymes and lipophilic compounds from adher-
ing to the walls of reaction coils, thus preventing peak
broadening [27]. Moreover, when on-line biodetection
systems are operated in the HPLC mode, organic modifiers
are automatically introduced via the HPLC gradient. When
testing MeOH, ACN, and IPA in the off-line biochemical
batch assay format, they were tolerated up to concentrations
of 10%, resulting in approximately half the fluorescence
signal compared to that obtained when organic modifiers
were not used.
Optimized conditions were derived from the abovemen-
tioned experiments performed in the off-line batch assay
format and subsequently translated to the on-line PAD
system in FIA mode. These final conditions were: a carrier
solution consisting of 10% MeOH and 100 mg/l Tween 20 at
af l o wr a t eo f1 0 0μl/min; SL-A containing potassium
phosphate buffer (50 mM; pH 7.8), rat liver microsomes
(50 μg/ml), HRP (18 U/ml), and SOD (14 U/ml), and SL-B
with the same buffer containing PEG6000 (1 mg/ml),
NADPH (44 μM), and 4-HPAA (1.2 mM). For continuous
ROS production (resulting in a stable fluorescent baseline),
paraquat was present in the optimized system in SL-B at a
concentration of 0.036 mM. Both superloops had a flow-rate
of 100 μl/min.
PAD system in flow-injection analysis mode
Before coupling the on-line PAD system to gradient HPLC,
it was first evaluated and validated in FIA mode.
Evaluation of the PAD system was done with three well-
known model ROS-producing compounds (i.e., paraquat,
menadione, and duroquinone), and two well-known model
antioxidants (L-ascorbic acid and glutathione). First, para-
quat was injected in triplicate at different concentrations
(1.0, 0.25, 0.06, 0.015, 0.004, 0.001, 0 mM) into the PAD
system in FIA mode. Figure 2a shows the resulting signals.
The highest concentration of paraquat resulted in fluores-
cence quenching. An analogous FIA trace for the redox
cycling compound menadione is depicted in Fig. 2b.
Figure 2c and d show the resulting PAD traces when L-
ascorbic acid and glutathione (well-known antioxidants)
were injected in triplicate in a dose-response manner,
respectively. It was shown that ascorbic acid acted as a
pro-oxidant compound at low concentrations (Fig. 2c). Pro-
oxidant effects of ascorbic acid at low concentrations were
previously demonstrated by Abudu et al. [34], who stated
that ascorbic acid can undergo one-electron reduction to
form an ascorbyl radical. Ascorbic acid can also switch
from being an antioxidant to being a pro-oxidant in the
presence of transition metals [35].
Thedirectantioxidanteffectof L-ascorbic was also shown
using the PAD system (without paraquat in SL-B) by first
injecting paraquat and then injecting a mixture of paraquat
and L-ascorbic acid. Figure 3 shows that the addition of L-
ascorbic acid neutralizes the ROS formed from paraquat.
The same effect is shown for menadione (Fig. 3).
To determine the effects of the test compounds paraquat,
menadione, L-ascorbic acid, and glutathione on the fluores-
cence baseline, injections of different concentrations of the
test compounds into the PAD system were performed
without HRP and SOD in SL-A. Menadione and duroqui-
none caused fluorescence signals when injected in concen-
trations larger then 0.8 and 0.4 mM, respectively. This
implies that these compounds can only be measured
efficiently at these or higher concentrations if a parallel
signal measuring their auto-fluorescence is employed, so
that this can be subtracted from the PAD signal. In order to
determine the relative pro-oxidant or antioxidant effects of
the compounds, and to compare the off-line batch assay
and the on-line assay (in FIA and HPLC mode) with each
other, the fluorescence signals per mole of the test
compound were determined from the data obtained in the
off-line batch assay and the PAD system in FIA and HPLC
modes (Table 1). When comparing the relative fluorescence
signals per mole of test compound obtained using the off-
line batch and both of the on-line systems, the relative
fluorescence signals appeared to differ significantly for
some compounds. This difference might be explained by
the pre-incubation step, which was only performed for the
off-line batch assays and not for the on-line PAD measure-
ments. In contrast, for the off-line batch assay and both of
the on-line PAD system formats, the measured pro-oxidant
or antioxidant effects were comparable for all test com-
pounds in terms of determinations of their individual pro-
oxidant or antioxidant effects. Although the results obtained
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were not similar, the comparable results still allowed the
off-line batch assay to be transformed into both on-line
assay formats. We can expect these relatively complex
assay systems to give slightly different assay characteristics
when performed under different assay conditions, like off-
line batch or on-line assay conditions. Therefore, we can
conclude that the off-line batch assay format can be
transferred to the present PAD system used to screen for
antioxidants and ROS-producing compounds.
Interday and intra-day variabilities were determined in
the on-line PAD system in FIA mode as follows: intraday
variability was determined by injecting paraquat (0.2 mM)
in triplicate at 3.5-hour time intervals into the PAD system.
The intraday variability was determined without changing
the contents of the superloops. For the interday variability,
paraquat (0.2 mM) was injected daily in triplicate for three
days with fresh solutions in the superloops each day.
Intraday variability was 3.3%±1.1% and interday variability
4.1%±0.6%, which are both within the ranges exhibited by
Fig. 2 Triplicate injections of a series of dilutions (dilution factor of
4) of different compounds into the PAD system used in FIA mode.
a The pro-oxidant paraquat (starting with 1.0 mM). b The pro-oxidant
menadione (starting with 0.15 mM). c The antioxidant ascorbic acid
(starting with 1.0 mM). d The antioxidant glutathione (starting with
25 mM)
Fig. 3 Injections (triplicates) of
different compounds into the
PAD system in FIA mode
(without the continuous addition
of a pro-oxidant): 1) paraquat
(0.05 mM); 2) paraquat
(0.05 mM) and ascorbic acid
(0.1 mM); 3) menadione
(0.03 mM); 4) menadione
(0.03 mM) and ascorbic acid
(0.1 mM)
876 Anal Bioanal Chem (2007) 388:871–879bioanalytical screening methods [27, 29]. Detection limits
(Table 1) were determined by triplicate injections of a series
of dilutions of every test compound. The detection limit
was defined as the concentration of test compound that gave
an average signal of three times the noise (S/N ratio=3).
The sensitivities obtained for the different compounds,
which are also intrinsically determined by their pro-oxidant
or antioxidant potencies, are also indicated in Table 1.
These sensitivities were of the same order as those obtained
with the off-line batch assay format (data not shown). Thus,
the present PAD system provided a useful novel rapid
screening tool for pro-oxidant and antioxidant activities of
individual compounds in mixtures in this respect too.
On-line coupling of the PAD system to gradient HPLC
The PAD system in gradient HPLC mode was evaluated by
analyzing the five test compounds after HPLC separation
with a decreasing flow-rate gradient. The advantage of this
decreasing flow-rate gradient lies with the initially high
flow-rate through the column at low concentrations of
organic modifier, which results in better eluting compound
resolution at the start of the gradient. At higher concen-
trations of organic modifier, the flow rates are obviously
gradually decreased (and the post-column counteracting
flow rates are gradually increased) in order to obtain a
continuous flow rate (1 ml/min) and concentration of
organic modifier (of 10%) after mixing in the post-column
counteracting gradient. This results in a constant flow rate
and organic modifier concentration (after the 1:9 split)
when entering the on-line PAD. The added value of this
approach is that alterations in the chromatographic method
can be made without much effect on the on-line PAD assay.
First, the individual test compounds were analyzed. The
test compounds were injected (in triplicate) in five different
concentrations prepared by serial dilution of 100 μl of stock
solution with 300 μl MeOH (30% v/v). Typical super-
imposed chromatograms of menadione and L-ascorbic acid
a r es h o w ni nF i g .4a and b, respectively. At high
concentrations of L-ascorbic acid, two peaks were seen.
This was the result of overloading the analytical column, as
additional mass spectrometry data showed that both peaks
were from L-ascorbic acid (data not shown). The relative
pro-oxidant or antioxidant response of every test compound
in the PAD system used in gradient HPLC mode is shown
in Table 1. The sensitivities obtained for the test com-
pounds are also depicted in Table 1. When comparing the
PAD system used in HPLC mode with the PAD system
used in FIA mode and the off-line batch assays, it is seen
that all three assay formats allow the detection of both pro-
oxidants and antioxidants. The differences between the
three assay formats probably result from different factors,
such as the pre-incubation step applied in the off-line batch
assay format and the peak broadening of compounds during
the chromatographic separation. Another possible cause
derives from minor pro-oxidant or antioxidant impurities in
Fig. 4 a Superimposed PAD traces of menadione injected in different
amounts into the PAD system in HPLC mode (12.5, 50 and 200 μM
from bottom to top chromatogram, respectively). b Superimposed
PAD traces of ascorbic acid injected in different amounts into the PAD
system in HPLC mode (50, 200 and 800 μM from top to bottom
chromatogram, respectively)
Table 1 Initial relative increases or decreases (in fluorescence units, FU) of different ROS-producing pro-oxidant compounds and antioxidants
compared to paraquat for the PAD system used in FIA mode, in gradient HPLC mode and for a traditional batch assay
Pro-oxidant/
Antioxidant
FIA PAD system
(FU/mol±SEM)
Detection limit for the
FIA PAD system (nmol)
HPLC PAD system
(FU/mol±SEM)
Detection limit for the
HPLC PAD system (nmol)
Batch assay set-up
(FU/mol±SEM)
Paraquat 1.00±0.08 0.07 1.00±0.33 0.9 1.00±0.05
Menadione 1.55±0.20 0.01 0.56±0.01 0.4 1.60±0.33
Duroquinone 0.13±0.02 0.04 0.36±0.19 1.3 0.16±0.07
Glutathione -2.20±0.03 1.9 -0.67±0.18 8.0 -1.01±0.04
Ascorbic acid -4.58±0.22 0.1 -1.35±0.13 0.2 -1.22±0.12
The detection limits of the PAD system used in the FIA and HPLC modes are also given
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from the test compounds in the on-line PAD system used in
HPLC mode, they would only influence the results obtained
in the off-line batch format and the on-line PAD system used
in FIA mode. However, comparable results are still obtained
(no more than threefold differences in measured pro-oxidant
or antioxidant effects were obtained per mole of test
compound) in the different experimental set-ups. Therefore,
it can be concluded that the PAD system used in gradient
HPLCmodecanbeeasilyapplied toandisa sensitive method
for the screening of individual compounds for their ROS-
producing capacity and antioxidant potentials.
The PAD system used in HPLC mode was also applied to
the detection of individual antioxidants and ROS-producing
compounds in mixtures. Typical PAD traces of two different
mixturesthatwereinjectedandseparatedonHPLCareshown
in Fig. 5a and b, respectively. Figure 5a shows that all three
ROS-producing compounds—paraquat, menadione and du-
roquinone—were individually identified as oxidant species.
The compounds in the second mixture, which contained two
antioxidants and two ROS-producing compounds, were
individually identified as antioxidants (L-ascorbic acid and
glutathione) and pro-oxidants (menadione and duroquinone).
Thus, mixtures in which ROS-producing compounds are
present together with antioxidants could effectively be
measured individually with the present PAD system in
gradient HPLC mode. When analyzing such mixtures with
traditional off-line batch assay formats, antioxidants can
counteract the effects of pro-oxidants thereby reducing or
even totally removing ability to detect the pro-oxidants. The
relatively low resolutions obtained in the PAD assay directly
reflect the resolutions resulting from the chromatographic
part of the total system. Since this study was a proof-of-
principle study, we did not perform a thorough optimization
of the chromatographic part of the system. The resolutions
that can be obtained with the PAD part of the system (used
in FIA mode) are shown in Fig. 2 and reflect the
performance of the assay. Connecting the PAD part to a
chromatographic separation system with higher resolution
will obviously result in higher resolution, which may be
needed when screening real life samples. The present PAD
system in HPLC mode therefore opens up new avenues to
the efficient and rapid screening of complex mixtures for
individual pro-oxidant and antioxidant components.
Conclusion
This paper presents the development and validation of a
HRS-based on-line post-column detection system for the
detection of ROS-producing compounds as well as anti-
oxidants in mixtures. Different parameters, such as sub-
strate (4-HPAA) and enzyme concentrations, reaction time,
temperature, additives, and organic modifier concentrations
were first optimized for the PAD system used in FIA mode.
Several ROS-producing compounds as well as antioxidants
were successfully measured with the optimized system. The
intraday and interday variabilities of the PAD system used
in FIA mode were determined and found to be lower than
5%. Good sensitivities, at least comparable with similar off-
line batch assay formats for individual compounds, were
obtained. On-line coupling of the novel PAD system to
gradient HPLC permitted the screening of individual
compounds in mixtures for ROS-producing and antioxidant
properties. It should be noted, however, that compounds
that show fluorescence quenching or intrinsic fluorescence
may interfere with the methodology. However, it may be
possible to adjust the system so that another split directs
some of the flow to a second on-line assay that measures
these artifacts with a “negative control PAD system” in
order to detect such interferences. This PAD system used in
gradient HPLC mode is potentially of great value to drug
discovery and toxicology and food research.
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Fig. 5 a PAD trace for a mixture of three pro-oxidants injected into
the PAD system in HPLC mode. Injected compounds are: paraquat
(0.12 mM; 3.5 min), menadion (0.05 mM; 17.5 min), and duroqui-
none (0.17 mM; 18.5 min). b PAD trace of a mixture of two pro-
oxidants and two antioxidants injected into the PAD system in HPLC
mode. Iinjected compounds are: ascorbic acid (0.14 mM; 5 min),
glutathione (0.4 mM; 8 min), menadion (0.05 mM; 17.5 min), and
duroquinone (0.17 mM; 18.5 min)
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